Related Experiment Video
Updated: Aug 19, 2026

Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice
Published on: November 16, 2011
Insulin resistance in short children with intrauterine growth retardation
P L Hofman1, W S Cutfield, E M Robinson
1Department of Pediatrics, University of Auckland, New Zealand.
Insights
Short children born with intrauterine growth retardation (IUGR) show impaired insulin sensitivity. This early insulin resistance may predict future development of type 2 diabetes and other adult diseases.
Area of Science:
- Pediatrics
- Endocrinology
- Metabolic Research
Background:
- Intrauterine growth retardation (IUGR) is linked to adult diseases like hypertension and diabetes.
- Insulin resistance is a common factor in these adult-onset conditions.
- Early identification of metabolic dysfunction in IUGR children is crucial.
Purpose of the Study:
- To investigate insulin sensitivity in prepubertal children with IUGR.
- To compare insulin sensitivity and acute insulin response between IUGR and normal birth weight children.
Main Methods:
- Compared two groups of short prepubertal children: IUGR (n=15) and normal birth weight (n=12).
- Utilized a modified frequently sampled intravenous glucose tolerance test.
- Calculated insulin sensitivity index, acute insulin response, and glucose effectiveness.
Main Results:
- IUGR children exhibited significantly lower insulin sensitivity (P=0.0048).
- IUGR subjects showed a higher acute insulin response (P=0.005).
- No significant difference in glucose effectiveness was observed between groups.
Conclusions:
- Short prepubertal children with IUGR have impaired insulin sensitivity.
- This insulin resistance may serve as an early marker for adult-onset diabetes.
- Early intervention strategies can be developed for at-risk IUGR children.
Abstract:
Epidemiological studies have demonstrated an association between intrauterine growth retardation and an increased risk of adult diseases that include essential hypertension, noninsulin-dependent diabetes mellitus, and ischemic heart disease. A common feature of these diseases is insulin resistance. To investigate whether abnormal insulin sensitivity was a characteristic of subjects with intrauterine growth retardation (IUGR), we compared two groups of short prepubertal children: a group with IUGR (birth weight less than the tenth percentile; n = 15) and a normal birth weight group (n = 12). Subjects underwent a modified frequently sampled iv glucose tolerance test that permitted calculation of the acute insulin response, insulin sensitivity index, and glucose effectiveness. A marked difference in the insulin sensitivity index was noted between groups, with the IUGR group being less insulin sensitive [6.9 vs. 16.9 10(-4)min-1.(microU/mL); P = 0.0048]. The acute insulin response was also significantly different between groups, with IUGR subjects having higher insulin levels (445 vs. 174 microU/mL; P = 0.005). There was no difference in glucose effectiveness between groups. Short prepubertal IUGR children have a specific impairment in insulin sensitivity compared to their normal birth weight peers. In short IUGR children, impaired insulin sensitivity is a potential marker for the early identification and intervention in the development of late adult-onset noninsulin-dependent diabetes mellitus.
More Related Videos
08:03Glucose Uptake Measurement and Response to Insulin Stimulation in In Vitro Cultured Human Primary Myotubes
Published on: June 25, 2017
08:13Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test (OGTT) and Insulin Tolerance Test (ITT)
Published on: January 7, 2018
Related Concept Videos
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
Type II Diabetes I: Introduction
Type II Diabetes II: Pathophysiology